Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PTHL
PTHL logo

PTHL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
12.31M
EV/OCF(TTM)
--
P/S(TTM)
42.05
iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
Show More

Events Timeline

(ET)
2026-01-13
08:50:00
Pheton Holdings Renames to iTonic Holdings, Changes Ticker to ITOC
select
2025-10-23 (ET)
2025-10-23
16:44:05
Pheton Holdings Notified of Noncompliance by Nasdaq
select
2025-08-01 (ET)
2025-08-01
09:30:52
Pheton denies any involvement in 'any form of stock price manipulation'
select
2025-07-29 (ET)
2025-07-29
08:14:52
Bear Cave sees Pheton Holdings 'being manipulated,' risk of 'collapse'
select
link

News

Globenewswire
8.5
2025-12-05Globenewswire
Pheton Acquires 51% of iTonic, Expanding into Home Health Market
  • Strategic Acquisition: Pheton successfully acquires 51% of iTonic, marking its expansion into the U.S. home health market, which is expected to enhance the company's competitiveness in the healthcare technology sector.
  • Equity Structure Adjustment: The transaction involves issuing 4 million new Class A shares to selling shareholders, along with warrants for 3 million shares, aimed at incentivizing shareholders through performance milestones and strengthening corporate governance.
  • Market Potential: iTonic addresses 125,000 preventable deaths and $500 billion in annual U.S. health costs linked to medication non-adherence, and Pheton's acquisition will facilitate more efficient home health solutions.
  • Future Outlook: Pheton's CEO states that this acquisition will drive the company's transition to AI-driven health solutions, expected to create long-term value for shareholders and further solidify its position in the healthcare industry.
Newsfilter
8.5
2025-12-05Newsfilter
Pheton Acquires 51% of iTonic, Expanding into Home Health Market
  • Strategic Acquisition: Pheton's successful acquisition of 51% of iTonic marks its expansion into the U.S. home health market, which is expected to enhance the company's competitiveness in the healthcare technology sector.
  • Equity Structure: The transaction involves issuing 4 million new Class A shares and 3 million warrants to the Selling Shareholders, aimed at incentivizing long-term growth through performance milestones.
  • Market Potential: iTonic addresses 125,000 preventable deaths and $500 billion in annual U.S. health costs linked to medication non-adherence, highlighting its significant market potential in home health.
  • Future Outlook: Pheton's CEO stated that the acquisition will integrate iTonic's AI-driven platform to improve service quality for patients and caregivers, with expectations of significant value creation for shareholders.
Barron's
2.0
2025-11-18Barron's
Small Asian Stocks Are Surging in U.S. Markets: Here's Why You Should Avoid Them.
  • Stock Performance: Pheton Holdings closed at a record $30.96 per share, achieving a market capitalization exceeding $200 million.
  • Sales and Profitability: The company reported less than half a million dollars in annual sales and has not yet turned a profit.
  • IPO Success: Since its initial public offering in September 2024, the stock has surged nearly 700%.
  • Lack of News: The significant stock increase occurred despite the absence of any major news or developments related to the company.
Benzinga
7.0
2025-08-11Benzinga
Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets
  • Pump-and-Dump Scams: The Bear Cave newsletter has highlighted a scheme where scammers use WhatsApp and fake investment firms to manipulate U.S.-listed Chinese stocks, leading to significant financial losses for investors through false rumors and sudden stock crashes.

  • Targeted Stocks and Resources: The Bear Cave identified six stocks potentially at risk of being targeted next and launched a website, StopNasdaqChinaFraud.com, to gather evidence against the fraudsters, urging investors to be cautious of unusual promotions on social media.

Globenewswire
7.0
2025-08-04Globenewswire
INVESTOR ALERT: Morris Kandinov LLP Investigating PTHL, EDHL, CIGL, and LXEH; Stockholders are Encouraged to Contact the Firm
  • Investigation of Pump-and-Dump Schemes: Morris Kandinov LLP is investigating claims from victims of pump-and-dump schemes involving several companies, including Pheton Holdings Ltd and Everbright Digital Holding Limited, where scammers posed as financial advisors in WhatsApp groups.

  • Contingency Fee Representation: The law firm offers representation on a contingency fee basis, meaning victims do not pay fees or expenses upfront, and they encourage affected individuals to reach out for legal assistance.

Benzinga
7.5
2025-08-02Benzinga
Benzinga Bulls And Bears: Celestica, Carvana, Novo Nordisk — And Fed Holds Rates Despite Trump Pressure
  • Federal Reserve and Market Reactions: The Federal Reserve maintained interest rates at 4.25-4.50%, despite disappointing job growth and rising inflation, leading to a significant market sell-off with major indices dropping 1-2%. This has increased speculation for a potential rate cut in September amid political pressures on the Fed.

  • Stock Performance Highlights: Notable stock movements included Celestica and Carvana experiencing gains due to strong earnings reports, while Novo Nordisk and several chipmakers like NVIDIA faced sharp declines following negative news and tariff concerns.

Valuation Metrics

The current forward P/E ratio for Pheton Holdings Ltd (PTHL.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Pheton Holdings Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding PTHL

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Pheton Holdings Ltd (PTHL) stock price today?

The current price of PTHL is 0 USD — it has increased 0

What is Pheton Holdings Ltd (PTHL)'s business?

iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.

What is the price predicton of PTHL Stock?

Wall Street analysts forecast PTHL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PTHL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Pheton Holdings Ltd (PTHL)'s revenue for the last quarter?

Pheton Holdings Ltd revenue for the last quarter amounts to NaN USD, decreased

What is Pheton Holdings Ltd (PTHL)'s earnings per share (EPS) for the last quarter?

Pheton Holdings Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Pheton Holdings Ltd (PTHL). have?

Pheton Holdings Ltd (PTHL) has 10 emplpoyees as of April 02 2026.

What is Pheton Holdings Ltd (PTHL) market cap?

Today PTHL has the market capitalization of 0.00 USD.